Zhengye Biotechnology Holding Limited Ordinary Shares (ZYBT) — Capital Reinvestment Ratio
Zhengye Biotechnology Holding Limited Ordinary Shares (ZYBT) has a Capital Reinvestment Ratio of 0.68x as of December 2025, meaning it reinvests 1% of its operating cash flow ($41.05 Million) in capital expenditures ($27.77 Million). See how much free cash does Zhengye Biotechnology Holding Limited Or generate to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Zhengye Biotechnology Holding Limited Ordinary Shares Capital Reinvestment Ratio (2021–2025)
This chart tracks Zhengye Biotechnology Holding Limited Ordinary Shares's Capital Reinvestment Ratio across 5 annual periods.
Annual Capital Reinvestment Ratio for Zhengye Biotechnology Holding Limited Ordinary Shares (2021–2025)
Year-by-year Capital Reinvestment Ratio for Zhengye Biotechnology Holding Limited Ordinary Shares from 2021 to 2025. For live market cap and broader valuation context, see Zhengye Biotechnology Holding Limited Or market capitalisation.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.68x | $41.05 Million | $27.77 Million | ▲ +0.0% |
| 2024 | 0.68x | $41.05 Million | $27.77 Million | ▲ +181.1% |
| 2023 | 0.24x | $48.18 Million | $11.60 Million | ▼ -84.7% |
| 2022 | 1.58x | $17.34 Million | $27.33 Million | ▲ +89.9% |
| 2021 | 0.83x | $31.81 Million | $26.40 Million | — |